早期唇及口腔鳞状细胞癌前哨淋巴结活检:巴西真实世界经验
这项回顾性研究纳入巴西七家中心20年间的407例cN0期唇及口腔鳞状细胞癌患者,评估前哨淋巴结活检的准确性与肿瘤学结果。隐匿性转移率为23.1%,区域失败率为5.4%,假阴性率为5.4%;5年区域无复发生存率85.3%、无病生存率77.1%、总生存率73.7%、疾病特异性生存率86.7%。作者认为该技术在真实世界不同场景中可行且肿瘤学安全。
要点
- 407例cN0期唇及口腔鳞癌患者接受前哨淋巴结活检,隐匿性转移率23.1%。
- 区域失败率5.4%,假阴性率5.4%,5年区域无复发生存率85.3%。
- 5年无病生存率77.1%、总生存率73.7%、疾病特异性生存率86.7%。
核心结论
- 在真实世界场景中,唇及口腔鳞状细胞癌患者的前哨淋巴结活检在不同机构中可行且肿瘤学安全,隐匿性淋巴结转移率和假阴性率与选择性颈淋巴结清扫相似,长期生存与历史报道相似。
研究设计与样本
- 回顾性研究,纳入巴西七家中心,共407例cN0期唇及口腔鳞状细胞癌患者,研究跨度20年。
主要发现
- 隐匿性转移率为23.1%,22例(5.4%)出现区域失败。
- 5年随访时,区域无复发生存率为85.3%,无病生存率为77.1%,总生存率为73.7%,疾病特异性生存率为86.7%。
- 假阴性率为5.4%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to evaluate the accuracy and oncological results of sentinel lymph node biopsy in patients with early lip and oral cavity squamous cell carcinoma (SCC) in a real-world scenario. METHODS: Retrospective study including seven Brazilian centers. RESULTS: Four-hundred and seven cN0 patients were accrued for 20 years. The rate of occult metastasis was 23.1% and 22 patients (5.4%) had regional failure. We found, for 5 years of follow-up, 85.3% of regional recurrence-free survival; 77.1% of disease-free survival; 73.7% of overall survival; and 86.7% of disease-specific survival. The rate of false-negative cases was 5.4%. CONCLUSION: In a real-world scenario, sentinel lymph node biopsy for patients with SCC of the lip and oral cavity proved feasible in different settings and to be oncologically safe, with similar rates of occult lymph node metastasis and false-negative cases, when compared to elective neck dissection, and with similar long-term survival to that reported historically.
引用
- Matos LL, Capuzzo RC, Pedruzzi PAG, et al. Sentinel lymph node biopsy for early squamous cell carcinoma of the lip and oral cavity: Real-world experience in Brazil. Head Neck. 2022. PMID: 35427429. doi:10.1002/hed.27061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。